» Articles » PMID: 7012549

Nonspecific Stimulation of Antibacterial Resistance by a Synthetic Thymic Factor (FTS) in Mice

Overview
Date 1980 Jan 1
PMID 7012549
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Treatment of mice with 0.01-1 microgram of a synthetic serum thymic factor (FTS) significantly increased their resistance to lethal doses (1-5 X 10(6) organisms) of Salmonella typhimurium LT2 (LT2). At least seven injections of FTS were necessary for induction of resistance, since the effects of one to three injections were variable. FTS additively potentiated the protective immunity to LT2 induced by immunization with avirulent mutant of LT2, irrespective of the structural components of the cell wall lipopolysaccharides of the mutants, which are basically correlated with their immunogenicity and virulence. Activated macrophages have a direct role in the induction of host resistance, since peritoneal macrophages from FTS-treated DBA/2 mice which are resistant to the doses of LT2 used could by themselves retard bacterial growth in vitro, whereas those from CBA/N mice which are relatively susceptible to LT2 did not inhibit bacterial growth without intervention of FTS-treated syngeneic T cells.

Citing Articles

Activation of polyclonal antibody responses by a synthetic serum thymic factor (FTS) in CBA/N mice.

Matsumoto T, Shibata M Immunology. 1982; 45(2):293-301.

PMID: 7037618 PMC: 1555273.